Corcept Therapeutics (CORT) Files 4.2M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Join SI Premium – FREE
Corcept Therapeutics (Nasdaq: CORT) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 4,202,443 shares of Common Stock on behalf of Selling Shareholders.
Corcept will not receive proceeds from the secondary offering.
Corcept will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Gossamer Bio raises up to $250M in private placement for PAH drug
- Breeze Acquisition Corp. II gets Nasdaq notice for late 10-Q filings
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
